PROMIS NEUROSCIENCES INC COMMON SHARES (OTCMKTS:ARFXF) Can’t Be More Risky. Short Interest Increased

June 18, 2018 - By Darrin Black

ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF) Logo

The stock of PROMIS NEUROSCIENCES INC COMMON SHARES (OTCMKTS:ARFXF) registered an increase of 112.92% in short interest. ARFXF’s total short interest was 37,900 shares in June as published by FINRA. Its up 112.92% from 17,800 shares, reported previously. With 205,600 shares average volume, it will take short sellers 0 days to cover their ARFXF’s short positions. The short interest to PROMIS NEUROSCIENCES INC COMMON SHARES’s float is 0.02%.

The stock decreased 3.17% or $0.01 during the last trading session, reaching $0.29. About 27,860 shares traded. ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF) has 0.00% since June 18, 2017 and is . It has underperformed by 12.57% the S&P500.

ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops precision medicine therapeutics for treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company has market cap of $72.52 million. The Company’s proprietary target discovery engine is based on the use of two complementary techniques. It currently has negative earnings. The firm applies its thermodynamic, computational discovery platform?ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: